From January 1, 2024 to March 31, 2024, the company has repurchased 1,148,000 shares, representing 0.67% for CNY 13.11 million. With this, the company has completed the repurchase of 1,872,500 shares, representing 1.1% for CNY 22.08 million under the buyback announced on May 9, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10.29 CNY | +3.83% | -4.72% | -29.38% |
1st Jan change | Capi. | |
---|---|---|
-29.38% | 240M | |
+10.73% | 7.96B | |
+5.95% | 7.66B | |
-0.58% | 5.88B | |
-6.11% | 3.72B | |
-13.21% | 3.47B | |
-15.49% | 1.16B | |
-26.41% | 1.12B | |
+9.98% | 948M | |
-11.42% | 905M |
- Stock Market
- Equities
- 603079 Stock
- News Zhejiang Shengda Bio-Pharm Co., Ltd.
- Tranche Update on Zhejiang Shengda Bio-Pharm Co., Ltd.'s Equity Buyback Plan announced on May 9, 2023.